Changing laboratory may be necessary when lead times, volumes, regulatory needs or the development of a brand change. Yet a manufacturing transfer involves risks: differences in equipment, supply of materials, packaging, rights to the formula and continuity of traceability. The project must be prepared before stocks run out in order to avoid a commercial disruption.

Start with the rights and the available documents

Check who owns the formula and what the initial contract allows to be transferred. Gather the product specifications, information on raw materials, the relevant methods, the packaging characteristics and the available quality documents. If some data is confidential or belongs to the initial supplier, an appropriate agreement may be necessary.

A brand that only has the INCI label does not necessarily have all the information required to reproduce a formula identically.

Assess feasibility at the new manufacturer

The receiving laboratory must study the available materials, its equipment, the manufacturing parameters and the packaging. Pilot tests and comparative approvals may be necessary. A technically described formula can give different sensory results if the processes or suppliers change.

Before promising equivalence, define the acceptance criteria: appearance, fragrance, viscosity, behaviour in the container and appropriate controls.

Protect commercial continuity

Calculate the safety stock, the speed of sales and the time required for the transition. Plan an overlap phase where feasible: the old product remains available while the new site carries out the necessary approvals. Avoid changing the formula, the bottle and the design at the same time if the main objective is to maintain the same product experience.

Communication to distributors must be based on verified information, especially if product changes affect the information provided to customers.

Operators in laboratory clothing near a line

Update the documentary obligations

Depending on the market, a change of manufacturer or formula may require documentary or regulatory updates. For the European Union, the Responsible Person must examine the consequences for the Product Information File, the safety assessment and the relevant notifications. The transfer therefore cannot be reduced to comparing two factory prices.

Frequently asked questions

Can a product be reproduced from its INCI list?

Not reliably: the INCI list gives neither the complete concentrations nor the process.

Do tests need to be repeated?

An assessment is necessary; the tests required depend on the changes and the context.

How much time should be allowed for the transfer?

The lead time depends on the available data, the technical study and the necessary approvals.

Study your manufacturing transfer

Present the products concerned, the quantities, the continuity constraints and the documents you have to BIOCYLAB.

Request an industrial transfer study